103 related articles for article (PubMed ID: 15604257)
1. Endothelin receptor B inhibition triggers apoptosis and enhances angiogenesis in melanomas.
Lahav R; Suvà ML; Rimoldi D; Patterson PH; Stamenkovic I
Cancer Res; 2004 Dec; 64(24):8945-53. PubMed ID: 15604257
[TBL] [Abstract][Full Text] [Related]
2. Endothelin receptor B antagonists decrease glioma cell viability independently of their cognate receptor.
Montgomery JP; Patterson PH
BMC Cancer; 2008 Nov; 8():354. PubMed ID: 19040731
[TBL] [Abstract][Full Text] [Related]
3. First-in-Human Proof-of-Concept Study: Intralesional Administration of BQ788, an Endothelin Receptor B Antagonist, to Melanoma Skin Metastases.
Wouters J; Hunger RE; Garrod T; Dubuis B; Hunziker T; van den Oord JJ; Lahav-le Coutre R
Oncologist; 2015 Oct; 20(10):1121-2. PubMed ID: 26330458
[TBL] [Abstract][Full Text] [Related]
4. An endothelin receptor B antagonist inhibits growth and induces cell death in human melanoma cells in vitro and in vivo.
Lahav R; Heffner G; Patterson PH
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11496-500. PubMed ID: 10500205
[TBL] [Abstract][Full Text] [Related]
5. Endothelin receptor B is required for the expansion of melanocyte precursors and malignant melanoma.
Lahav R
Int J Dev Biol; 2005; 49(2-3):173-80. PubMed ID: 15906230
[TBL] [Abstract][Full Text] [Related]
6. Targeting the endothelin axis in human melanoma: combination of endothelin receptor antagonism and alkylating agents.
Berger Y; Bernasconi CC; Juillerat-Jeanneret L
Exp Biol Med (Maywood); 2006 Jun; 231(6):1111-9. PubMed ID: 16741059
[TBL] [Abstract][Full Text] [Related]
7. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria.
Zhang XD; Zhang XY; Gray CP; Nguyen T; Hersey P
Cancer Res; 2001 Oct; 61(19):7339-48. PubMed ID: 11585775
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.
Spinella F; Rosanò L; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
Cancer Res; 2007 Feb; 67(4):1725-34. PubMed ID: 17308114
[TBL] [Abstract][Full Text] [Related]
10. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
[TBL] [Abstract][Full Text] [Related]
11. Endothelin B receptor antagonists block proliferation and induce apoptosis in glioma cells.
Paolillo M; Russo MA; Curti D; Lanni C; Schinelli S
Pharmacol Res; 2010 Apr; 61(4):306-15. PubMed ID: 19931393
[TBL] [Abstract][Full Text] [Related]
12. Endothelin receptor-A is required for the recruitment of antitumor T cells and modulates chemotherapy induction of cancer stem cells.
Coffman L; Mooney C; Lim J; Bai S; Silva I; Gong Y; Yang K; Buckanovich RJ
Cancer Biol Ther; 2013 Feb; 14(2):184-92. PubMed ID: 23192269
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-B receptor blockade inhibits molecular effectors of melanoma cell progression.
Rosanò L; Spinella F; Genovesi G; Di Castro V; Natali PG; Bagnato A
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S136-9. PubMed ID: 15838263
[TBL] [Abstract][Full Text] [Related]
14. p53-Independent induction of apoptosis in human melanoma cells by a bcl-2/bcl-xL bispecific antisense oligonucleotide.
Strasberg Rieber M; Zangemeister-Wittke U; Rieber M
Clin Cancer Res; 2001 May; 7(5):1446-51. PubMed ID: 11350916
[TBL] [Abstract][Full Text] [Related]
15. Antiapoptotic role of endogenous nitric oxide in human melanoma cells.
Salvucci O; Carsana M; Bersani I; Tragni G; Anichini A
Cancer Res; 2001 Jan; 61(1):318-26. PubMed ID: 11196180
[TBL] [Abstract][Full Text] [Related]
16. Myeloperoxidase upregulates endothelin receptor type B expression.
Lau D; Szöcs K; Klinke A; Rudolph T; Rudolph V; Streichert T; Blankenberg S; Baldus S
J Mol Cell Cardiol; 2014 Apr; 69():76-82. PubMed ID: 24417960
[TBL] [Abstract][Full Text] [Related]
17. Silymarin inhibits melanoma cell growth both in vitro and in vivo by targeting cell cycle regulators, angiogenic biomarkers and induction of apoptosis.
Vaid M; Singh T; Prasad R; Katiyar SK
Mol Carcinog; 2015 Nov; 54(11):1328-39. PubMed ID: 25174976
[TBL] [Abstract][Full Text] [Related]
18. [Effect of endothelin-1 and its antagonists on the expression of endothelin receptors mRNA in HSC-T6 cells].
Zhang J; Zhang ZT; Wang Y; Wang P; Li JS; Zhou YZ
Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(21):1395-7. PubMed ID: 16318777
[TBL] [Abstract][Full Text] [Related]
19. Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis.
Gupta S; Hastak K; Afaq F; Ahmad N; Mukhtar H
Oncogene; 2004 Apr; 23(14):2507-22. PubMed ID: 14676829
[TBL] [Abstract][Full Text] [Related]
20. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
